Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1600 1635
This examiner grants 45% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17532636 | OLIGONUCLEOTIDES FOR DGAT2 MODULATION | Non-Final OA | UNIVERSITY OF MASSACHUSETTS |
| 16999759 | O-METHYL RICH FULLY STABILIZED OLIGONUCLEOTIDES | Non-Final OA | UNIVERSITY OF MASSACHUSETTS |
| 18558886 | USE OF CHEMICAL EPIGENETIC MODIFIERS TO MODULATE GENE EXPRESSION FROM VECTORS | Non-Final OA | The University of North Carolina at Chapel Hill |
| 18310891 | ALKENYL SUBSTITUTED 2,5-PIPERAZINEDIONES, COMPOSITIONS, AND USES THEREOF | Non-Final OA | Massachusetts Institute of Technology |
| 17101545 | HIGH THROUGHPUT GENE EDITING SYSTEM AND METHOD | Non-Final OA | Recursion Pharmaceuticals, Inc. |
| 18315781 | METHOD FOR PRODUCING RNA MOLECULE COMPOSITIONS | Non-Final OA | CureVac SE |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy